• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Alembic’s Ophthalmic Solution gets USFDA approval biospectrumasia
    April 23, 2019
    Alembic Pharmaceuticals Limited recently announced that the company has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Bimatoprost Ophthalmic Solution, 0.03%.
  • Alembic Pharmaceuticals gets US FDA nod for ophthalmic solution expressbpd
    December 11, 2018
    The approved product is therapeutically equivalent to the reference listed drug product Patanol ophthalmic solution, 0.1 per cent, of Novartis Pharmaceuticals Corporation

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service